Avidity Biosciences Competitors and Similar CompaniesClear all
Avidity Biosciences's competitors and similar companies include Argenx, SNIPR Biome, GT Apeiron Therapeutics and Mologic.
 Avidity Biosciences Avidity Biosciences is a biotech company developing oligonucleotide-based therapies called antibody oligonucleotide conjugates (AOC). |  Argenx Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. |  SNIPR Biome SNIPR Biome is a biotech company using CRISPR/Cas technology for drug development for difficult-to-treat infections. |  Mologic In 2003, two quirky scientists vowed to make the world a better place, after learning their trades in some of the world’s biggest scientific organisations. | ||
Founding Date | Founding Date 2013 | Founding Date 2008 | Founding Date 2017 | Founding Date 2019 | Founding Date 2003 |
Type | Type Public | Type Public | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Gent, BE HQ Minato City, JP Breda, NL Genève, CH Boston, US | Locations København, DK HQ | Locations HQ | Locations Thurleigh, GB HQ |
Employees | Employees 25336% increase | Employees 1,599 | Employees 432% increase | Employees N/A | Employees 652% decrease |
Valuation ($) | Valuation ($) 5.3 b | Valuation ($) 33.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $18.8m (FY, 2025) | Revenue (est.) $4.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($684.6m) (FY, 2025) | Net income $1.3b (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 50m (about 7 years ago) | Latest funding round $ 27m (almost 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 131m | Total funding raised $ 396.8m | Total funding raised $ 50m | Total funding raised $ 27m | Total funding raised $ 8m |
For sources of this data, please see the company profile
View Company Profiles
Argenx
HQ
Gent, BE
Employees
1,599
Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
View companySNIPR Biome
HQ
København, DK
Employees
43↑ 2% increase
SNIPR Biome is a biotech company using CRISPR/Cas technology for drug development for difficult-to-treat infections.
View companyMologic
HQ
Thurleigh, GB
In 2003, two quirky scientists vowed to make the world a better place, after learning their trades in some of the world’s biggest scientific organisations.
View company